Understanding Liver Cancer | Stony ...

Dr. Amna Sher

Claim this profile

Stony Brook University Medical Center

Studies Lung Cancer
Studies Squamous Cell Carcinoma
9 reported clinical trials
14 drugs studied

Area of expertise

1Lung Cancer
Amna Sher has run 5 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
metastatic
Stage III
2Squamous Cell Carcinoma
Amna Sher has run 3 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
metastatic
locally advanced
Stage IV

Affiliated Hospitals

Image of trial facility.
Stony Brook University Medical Center
Image of trial facility.
Stony Brook University Cancer Center

Clinical Trials Amna Sher is currently running

Image of trial facility.

Pembrolizumab + Radiation vs Chemotherapy + Radiation

for Head and Neck Cancer

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Image of trial facility.

Chemotherapy + Immunotherapy vs. Immunotherapy

for Advanced Lung Cancer

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3

More about Amna Sher

Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Amna Sher has experience with
  • Pembrolizumab
  • Carboplatin
  • Pemetrexed
  • Ladiratuzumab Vedotin
  • 9-ING-41
  • Anti-PD-(L)1 Antibody Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Amna Sher specialize in?
Is Amna Sher currently recruiting for clinical trials?
Are there any treatments that Amna Sher has studied deeply?
What is the best way to schedule an appointment with Amna Sher?
What is the office address of Amna Sher?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security